NCT01218776 International Survey of Acute Coronary Syndromes
| NCT ID | NCT01218776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bologna |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 36,000 participants |
| Start Date | 2010-09-28 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 36,000 participants in total. It began in 2010-09-28 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The International Registry of Acute Coronary Syndromes registry study (ISACS) is both a retrospective and prospective study which was designed in order to obtain data of patients with acute coronary syndromes, and herewith control and optimize internationally guideline-recommended therapies in these countries
Eligibility Criteria
Inclusion Criteria: * acute coronary syndromes Exclusion Criteria: * under age or not able to give informed consent
Contact & Investigator
Raffaele Bugiardini, MD
PRINCIPAL INVESTIGATOR
University of Bologna
Frequently Asked Questions
Who can join the NCT01218776 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01218776 currently recruiting?
Yes, NCT01218776 is actively recruiting participants. Contact the research team at raffaele.bugiardini@unibo.it for enrollment information.
Where is the NCT01218776 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT01218776 clinical trial?
NCT01218776 is sponsored by University of Bologna. The principal investigator is Raffaele Bugiardini, MD at University of Bologna. The trial plans to enroll 36,000 participants.